Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,375 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04615065Recruiting
Biobank study collecting emergency data for very sick patients
This study collects health and sometimes blood sample information from people arriving at the emergency department with high-risk or serious conditions. The goal is to build a large emergency “biobank” to help researchers better understand and improve urgent care.
GroningenAges 18 years+ - NCT07836452RecruitingPhase 1
Study of a new drug for healthy people and those with Stargardt disease
This study tests a new drug called CITY-RBP4 in healthy volunteers and in people with Stargardt disease (STGD1), a genetic condition that causes vision loss. The goal is to see if the drug is safe and how it affects the body, which may help guide future treatments for Stargardt disease.
Melbourne, VictoriaAges 12–45 - NCT07835178Recruiting
High-pressure cutting balloon for hardened heart artery blockages
This study tests a special balloon that can cut through hardened calcium in heart arteries before placing a stent. It may help people with severe artery calcification get a better stent placement.
Xi'an, ShaanxiAges 18 years+ - NCT07834931Recruiting
Spine implant for low back pain from disc degeneration
This study tests an implant placed in the lower spine to treat back pain caused by disc degeneration. It aims to see if the implant helps reduce pain and improve function in people who have not improved with other treatments.
Madrid, MadridAges Any age - NCT07840196RecruitingPhase 1
Investigational drug NG004 for recent spinal cord injury
This trial tests a new drug called NG004 given by injection around the spinal cord. It aims to help people with recent incomplete spinal cord injuries recover function. The drug is given within the first month after injury and may be an option for those who meet the health criteria.
BayreuthAges 18–75 - NCT07834736Recruiting
Titanium implant for lower back disc pain
This study tests a new titanium implant to help stabilize the lower spine in people with painful, worn-out discs. It aims to see if the implant works well and is safe in everyday practice.
Madrid, MadridAges Any age - NCT07840326RecruitingPhase 2
Study of SUN-627 for progressive multiple sclerosis
This study tests an experimental medicine called SUN-627 for people with progressive multiple sclerosis (MS) that is not currently flaring up. The goal is to see if it can slow down worsening disability without causing serious side effects.
Atlanta, GeorgiaAges 18–70 - NCT07834749Recruiting
Fortilink-SC device study for neck and spinal stenosis
This study tests a new spinal device to see how well it works for people with neck pain and spinal stenosis. It may help reduce pain and improve function.
Madrid, MadridAges Any age - NCT07839793RecruitingPhase 4
Using a device and app for Parkinson's medication
This study tests a new way to take your Parkinson's medication using a special device and an app, with the goal of making it easier to manage your symptoms. You'll use the device for 12 weeks and share your experiences through questionnaires.
Stockholm, Stockholm CountyAges 30 years+ - NCT07837427Recruiting
Different water pressures during minimally invasive back surgery
This study compares two different water pressures used during a minimally invasive back surgery to see if one causes fewer complications and gives the surgeon a clearer view. It aims to help improve recovery and surgical outcomes for people with lower back problems.
Kunming, YunnanAges 18–75 - NCT07839741RecruitingPhase 4
Lowering cholesterol with ezetimibe
This trial looks at how well ezetimibe, a medicine that lowers cholesterol, works when taken alone or alongside other cholesterol medicines. It may help people who need extra help lowering their LDL (bad) cholesterol.
PortoAges 18–75 - NCT07834840Enrolling by invitation
Diet education for gout patients on urate-lowering therapy
This trial tests whether extra diet advice helps people with gout who are already taking urate-lowering medicine. It might help them manage their condition better.
Suwon, Gyeonggi-doAges 19 years+ - NCT07835945Recruiting
Testing blood gas from artery vs fingertip in breathing distress
This trial compares blood drawn from an artery (arterial blood gas) with blood from a fingertip (capillary blood gas) to see if the fingertip test gives accurate enough results for patients in the emergency room with breathing problems caused by COPD or heart failure. It might help reduce the pain and discomfort of repeated artery tests.
NiceAges 18 years+ - NCT07836088Recruiting
Ultrasound muscle check for metabolic health
This study uses ultrasound scans to measure muscle mass in people with metabolic conditions like type 2 diabetes and obesity. It may help doctors understand how these conditions affect muscles and could lead to better care.
Zhangzhou, FujianAges 18 years+ - NCT07840508Recruiting
High-speed strength training for Parkinson's disease
This study tests a special exercise program that focuses on moving quickly to improve strength and movement in people with Parkinson's disease. It may help with walking and daily activities.
Coral Gables, FloridaAges 50–85 - NCT07835308RecruitingEarly Phase 1
Smart tuning of brain stimulation for better walking
This study is testing a new way to adjust deep brain stimulation (DBS) settings to improve walking in people with Parkinson's disease. If you have DBS and can walk with stimulation off, this trial may help fine-tune your treatment to improve your gait.
Minneapolis, MinnesotaAges 18 years+ - NCT07835256Recruiting
Virtual reality training for rheumatology staff
This trial tests a training program that combines online learning with virtual reality to help healthcare providers in rheumatology improve their skills. It may benefit patients by ensuring their care team is well-trained in managing rheumatic conditions.
Leiden, South HollandAges 18 years+ - NCT07837375Recruiting
Physical activity support app for COPD patients
This study tests a mobile app that helps people with COPD exercise more safely, possibly by giving them better tips and reminders. It aims to see if the app can improve their daily activity and overall wellbeing.
MontivilliersAges 18 years+ - NCT06462768Recruiting
Study of immune cell activity in systemic sclerosis
This study looks at a specific type of immune cell activity (called neutrophil extracellular traps) in the blood of people with systemic sclerosis, other connective tissue diseases, and healthy volunteers. It aims to understand how these cells may be involved in the disease and could lead to better treatments.
ReimsAges 18 years+ - NCT06466018Recruiting
Eye disorder biomarkers study for European adults
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
ParisAges 18 years+ - NCT07826767RecruitingPhase 1/Phase 2
Gene therapy for inherited immune disease
This trial tests a new gene therapy (SGX-001) for chronic granulomatous disease caused by a specific genetic change. The treatment tries to fix the gene in your immune cells so they can fight infections better, and the trial will follow participants for up to 15 years to make sure it's safe and effective.
UlmAges 1.5 years+ - NCT05877391Recruiting
Collecting sexual and gender identity information in hospice
This study tests an approach to collect and use sexual orientation and gender identity (often called “SOGI”) information for people receiving hospice care. The goal is to help hospice teams better understand and support patients’ needs.
Aurora, ColoradoAges 18 years+ - NCT06463717Recruiting
Stem cell transplant timing for multiple myeloma with no cancer cells left
This trial looks at people with newly diagnosed multiple myeloma who have no detectable cancer cells after initial treatment. It aims to see if these patients can do well without a stem cell transplant or with a delayed one, reducing unnecessary side effects.
Hangzhou, ZhejiangAges 18–70 - NCT07827716RecruitingPhase 2
Testing terfenadine for relapsing multiple sclerosis
This study tests whether terfenadine, an allergy medicine, is safe and helpful for people with relapsing-remitting multiple sclerosis (MS). It may reduce MS activity and improve outcomes.
Wuhan, HubeiAges 18–65
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,375 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.